In the News

Latest COVID-19 research finds benefit from prone positioning, arthritis drugs

Prone positioning was helpful in patients not on mechanical ventilation, and two very small studies found positive outcomes with drugs used to treat rheumatoid arthritis. ACP members can join a bulk purchase of N95s and gowns.

Searching for stats on spread without symptoms

Infectious disease expert Jeanne Marrazzo, MD, FACP, discusses asymptomatic COVID-19, face coverings, outdoor versus indoor transmission, and tracing spread with ACP Hospitalist.

Rivaroxaban after discharge may reduce thromboembolic risk in medically ill

An industry-funded trial that gave medical patients rivaroxaban for 45 days after hospital discharge found decreased risk for a composite end point of symptomatic venous thromboembolism, myocardial infarction, nonhemorrhagic stroke, and cardiovascular death compared to placebo.

Guidance released for treating CAP in immunocompromised patients

The recommendations, based mainly on expert opinion, include general principles of empiric therapy and advice for specific pathogens, including methicillin-resistant Staphylococcus aureus and resistant gram-negative bacilli.

NSF rare with newer gadolinium-based contrast agents, review finds

Researchers advised caution when using newer gadolinium-based contrast agents in patients with impaired kidney function and suggested that more research on nephrogenic systemic fibrosis (NSF) is needed in this population.

Put words in our mouth

ACP Hospitalist Weekly wants readers to create captions for our new cartoon and help choose the winner. Pen the winning caption and win a $50 gift certificate good toward any ACP product, program, or service.